Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy
暂无分享,去创建一个
Camille Stephan-Otto Attolini | H. Heyn | C. Wellbrock | I. Arozarena | A. Matheu | S. Benitah | E. Santamaría | P. Aldaz | G. Kochan | D. Escors | A. Bocanegra | L. Chocarro | I. Larráyoz | E. Santamaría | F. J. Rodríguez-Baena | V. Moncho-Amor | B. Sanchez-Laorden | Irene Lasheras-Otero | Marta Redondo-Muñoz | Ana Olías-Arjona | Uxue Urdiroz-Urricelqui | Claudia Bigas | Maddalen Otaegi-Ugartemendia | A. Grier | E. Carrasco-Garcia | Adriá Caballé-Mestres | Monika Dzieciatkowska M | Josefina Martin | Florencio Marzo | Angelo D'Alessandro | Enrique Santamaría | Eva Santamaria | J. Martín | Enrique Santamaria | Eva Santamaría
[1] S. Vicent,et al. The regulators of peroxisomal acyl-carnitine shuttle CROT and CRAT promote metastasis in melanoma. , 2022, The Journal of investigative dermatology.
[2] Weinan Guo,et al. Metabolic rewiring directs melanoma immunology , 2022, Frontiers in Immunology.
[3] F. Zouein,et al. Role of ranolazine in heart failure: From cellular to clinic perspective. , 2022, European journal of pharmacology.
[4] Rui Hu,et al. PRMT5 Inhibition Promotes PD-L1 Expression and Immuno-Resistance in Lung Cancer , 2022, Frontiers in Immunology.
[5] G. McArthur,et al. Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies , 2021, Cancers.
[6] P. Ascierto,et al. Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy , 2021, Frontiers in Oncology.
[7] S. Spencer,et al. Melanoma subpopulations that rapidly escape MAPK pathway inhibition incur DNA damage and rely on stress signalling , 2021, Nature Communications.
[8] Kathleen M. Jagodnik,et al. Gene Set Knowledge Discovery with Enrichr , 2021, Current protocols.
[9] C. Wellbrock,et al. Identification of a Dexamethasone Mediated Radioprotection Mechanism Reveals New Therapeutic Vulnerabilities in Glioblastoma , 2021, Cancers.
[10] M. Caraglia,et al. S-Adenosylmethionine Inhibits Cell Growth and Migration of Triple Negative Breast Cancer Cells through Upregulating MiRNA-34c and MiRNA-449a , 2020, International journal of molecular sciences.
[11] F. André,et al. Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation. , 2020, Cell reports.
[12] Raphael Gottardo,et al. Integrated analysis of multimodal single-cell data , 2020, Cell.
[13] K. Flaherty,et al. Reversal of pre-existing NGFR-driven tumor and immune therapy resistance , 2020, Nature Communications.
[14] I. Csabai,et al. S-Adenosylmethionine Treatment of Colorectal Cancer Cell Lines Alters DNA Methylation, DNA Repair and Tumor Progression-Related Gene Expression , 2020, Cells.
[15] Z. Ronai,et al. PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity , 2020, Science Translational Medicine.
[16] Koichi S. Kobayashi,et al. MHC class I transactivator NLRC5 in host immunity, cancer and beyond , 2020, Immunology.
[17] M. Simoes-Costa,et al. Metabolic Reprogramming Promotes Neural Crest Migration via Yap/Tead Signaling. , 2020, Developmental cell.
[18] R. Garzon,et al. PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease. , 2020, JCI insight.
[19] J. Locasale,et al. Methionine metabolism in health and cancer: a nexus of diet and precision medicine , 2019, Nature Reviews Cancer.
[20] I. Barshack,et al. Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence , 2019, Cell.
[21] C. Wellbrock,et al. Phenotype plasticity as enabler of melanoma progression and therapy resistance , 2019, Nature Reviews Cancer.
[22] Paul J. Hoffman,et al. Comprehensive Integration of Single-Cell Data , 2018, Cell.
[23] Oscar Franzén,et al. PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data , 2019, Database J. Biol. Databases Curation.
[24] R. Satija,et al. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression , 2019, Genome Biology.
[25] Camille Stephan-Otto Attolini,et al. Identity Noise and Adipogenic Traits Characterize Dermal Fibroblast Aging , 2018, Cell.
[26] H. Takayanagi,et al. Arginine methylation controls the strength of γc-family cytokine signaling in T cell maintenance , 2018, Nature Immunology.
[27] K. Flaherty,et al. Toward Minimal Residual Disease-Directed Therapy in Melanoma , 2018, Cell.
[28] Kevin R. Moon,et al. Recovering Gene Interactions from Single-Cell Data Using Data Diffusion , 2018, Cell.
[29] Paul Hoffman,et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.
[30] P. Parren,et al. Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors , 2018, Nature Medicine.
[31] Yiling Lu,et al. A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma. , 2017, Cell reports.
[32] G. Freeman,et al. Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy. , 2017, Cancer cell.
[33] P. Carmeliet,et al. A Fatty Acid Oxidation-Dependent Metabolic Shift Regulates Adult Neural Stem Cell Activity , 2017, Cell reports.
[34] C. Wellbrock,et al. PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity. , 2017, Cell reports.
[35] Robert Damoiseaux,et al. Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression , 2017, Cell reports.
[36] A. D’Alessandro,et al. A three-minute method for high-throughput quantitative metabolomics and quantitative tracing experiments of central carbon and nitrogen pathways. , 2017, Rapid communications in mass spectrometry : RCM.
[37] K. Flaherty,et al. Targeted agents and immunotherapies: optimizing outcomes in melanoma , 2017, Nature Reviews Clinical Oncology.
[38] T. Honjo,et al. Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity , 2017, Proceedings of the National Academy of Sciences.
[39] Grace X. Y. Zheng,et al. Massively parallel digital transcriptional profiling of single cells , 2016, Nature Communications.
[40] A. Kernytsky,et al. MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis. , 2016, Cell reports.
[41] T. Golub,et al. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells , 2016, Science.
[42] Konstantinos J. Mavrakis,et al. Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5 , 2016, Science.
[43] K. Flaherty,et al. Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy , 2016, Cancer cell.
[44] N. Dhomen,et al. Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells , 2015, Molecular oncology.
[45] R. Lo,et al. Vemurafenib resistance reprograms melanoma cells towards glutamine dependence , 2015, Journal of Translational Medicine.
[46] S. Shen-Orr,et al. Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells. , 2015, Cell metabolism.
[47] A. Regev,et al. Spatial reconstruction of single-cell gene expression , 2015, Nature Biotechnology.
[48] Jun S. Song,et al. Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. , 2013, Cancer cell.
[49] R. Marais,et al. Effect of SMURF2 Targeting on Susceptibility to MEK Inhibitors in Melanoma , 2012, Journal of the National Cancer Institute.
[50] D. Iliopoulos,et al. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes , 2010, Proceedings of the National Academy of Sciences.
[51] J. Reis-Filho,et al. Oncogenic Braf induces melanocyte senescence and melanoma in mice. , 2009, Cancer cell.
[52] P. Oefner,et al. Quantitative analysis of 5'-deoxy-5'-methylthioadenosine in melanoma cells by liquid chromatography-stable isotope ratio tandem mass spectrometry. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[53] M. Schartl,et al. Multiple binding sites in the growth factor receptor Xmrk mediate binding to p59fyn, GRB2 and Shc. , 1999, European journal of biochemistry.
[54] K. M. Wyatt,et al. Ranolazine increases active pyruvate dehydrogenase in perfused normoxic rat hearts: evidence for an indirect mechanism. , 1996, Journal of molecular and cellular cardiology.
[55] K. Sakaguchi,et al. Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. , 1995, Journal of immunology.
[56] F. Roels,et al. Thioridazine: a selective inhibitor of peroxisomal β‐oxidation in vivo , 1985 .